GIVE MISS CALL ON :- +91 99774 99927

Tag Archives: NSE Nifty Intraday tips

CAPITALSTARS- INDIAN EQUITY MARKET OUTLOOK – 25 MAR 2019

Market Live: Nifty likely to open lower. The Nifty50 is likely to open lower on Monday following muted trend seen in other Asian markets. The index closed 64 points lower at 11,456 on Friday. Trends on SGX Nifty indicate a negative opening for the broader index in India, a fall of 59 points or 0.51

TOP CORPORATE NEWS- 22 MAR 2019

Cadila says no observation by USFDA on Ahmedabad R&D facility Shares of Cadila Healthcare slipped 2% in the last hour of the trading session on the BSE. “USFDA inspected the Pharmaceutical Technology Centre (PTC), the company’s state-of-the-art R&D facility located at Ahmedabad, dedicated to new product development of various niche dosage forms including solid oral,

CAPITALSTARS INDIAN EQUITY MARKET WRAP UP – 20 MAR 2019

The Sensex was down 222.14 points at 38164.61, while Nifty was down 64.10 points at 11456.90. Benchmark indices ended lower but off day’s low on Friday with Nifty finished below 11,500 level. At close, the Sensex was down 222.14 points at 38164.61, while Nifty was down 64.10 points at 11456.90. About 1009 shares have advanced,

CAPITALSTARS INDIAN EQUITY MARKET WRAP UP – 20 MAR 2019

Closing Bell: Sensex ends 159 points higher, Nifty at 10,685; Infosys up 3%. Closing Bell: Sensex ends higher, Nifty holds 11,500; PNB gains 3% Benchmark indices ended mixed after they remained range bound throughout Wednesday. The Sensex was up 23.28 points at 38386.75, while Nifty was down 11.40 points at 11521. About 1104 shares have

CAPITALSTARS – भारत में खरीदारी के लिए बेहतर हैं ये स्‍टॉक: 20 MAR 2019

Nifty, extended its winning streak for the seventh consecutive day, started the session on a firm note, and thereafter, it was a tough battle between the bulls and the bears. However, as the day progressed, the bears’ grip seemed to loosen as bulls managed to close above the 11,500 mark. The price action formed a

TOP CORPORATE NEWS- 19 MAR 2019

Zydus receives USFDA’s final approval for Acyclovir Ointment Zydus Cadila has received the final approval from the USFDA to market Acyclovir Ointment USP (US RLD- Zovirax@), 5%. It will be manufactured at the group’s Topical manufacturing facility at Ahmedabad. Acyclovir is an antiviral drug which stops the growth of certain viruses. This medication is used

CapitalStars FORUM